Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net loss	$ (1,866)	$ (27,547)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation	13,476	8,093
Amortization of intangible assets	13,552	11,023
Provision for doubtful accounts	861	1,180
Stock-based compensation	15,525	11,828
Deferred income taxes	(6,516)	(2,135)
Unrealized/realized (gain) loss on equity investment	274	(3,757)
Realized gain on bargain purchase		(4,920)
Non-cash interest	1,532	510
Other non-cash items	(344)	1,308
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable	66,568	(11,188)
Inventories	5,570	(449)
Prepaid expenses and other assets	(12,390)	1,188
Accounts payable	(40,050)	17,547
Accrued compensation and benefits	(3,851)	3,734
Deferred revenue	11,568	4,446
Other current and long-term liabilities	(2,298)	3,387
Net cash provided by operating activities	61,611	14,248
Cash flows from investing activities:
Capital expenditures	(11,140)	(13,309)
Business acquisitions		(97,581)
Proceeds from sale of investment	727	4,922
Net cash used in investing activities	(10,413)	(105,968)
Cash flows from financing activities:
Borrowings under Term Loan		100,000
Repayments of debt	(14,750)	(8,686)
Loan fees on borrowings	(545)	(1,494)
Repurchase of stock	(15,000)
Proceeds from issuance of common stock, net of tax withholding	5,005	(1,536)
Capital lease financing	(183)
Contingent consideration obligations	(3,856)
Deferred payments on an acquisition	(2,000)
Net cash (used in) provided by financing activities	(31,329)	88,284
Foreign currency effect on cash	(365)	94
Net increase (decrease) in cash	19,504	(3,342)
Cash and cash equivalents at beginning of period	121,139	130,450
Cash and cash equivalents at end of period	$ 140,643	$ 127,108